Real-world adoption of bevacizumab-bvzr biosimilar was retrospectively assessed, revealing switching between biosimilars and the reference product and utilization in extrapolated indications and combination regimens.
Jeffrey Thompson, PhD
Advertisement
Articles by Jeffrey Thompson, PhD
Advertisement
Latest Updated Articles
- Real-world Usage of Bevacizumab-bvzr Biosimilar in US Oncology Practice
Published: February 9th 2022 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Behind the Scenes of Multiple Myeloma Care: A Pharmacist’s View With Kelley L. Julian, PharmD, BCOP
2
AI–Enhanced SALT Score Improves Accuracy in Alopecia Areata Assessment
3
A "One-Two Punch" to Innovation? The Most Favored Nation Order and Broader US Drug Pricing Reform
4
Frequent Dining Out Linked to Higher Colorectal Cancer Risk
5
